AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Lewis Krauskopf
Apr. 28--MAHWAH, N.J. -- Shareholders of Schering-Plough Corp. greeted CEO Fred Hassan warmly Tuesday, in a sharp departure from annual meetings run by his predecessor.
Problems at the Kenilworth-based drug maker and its diving share price led to hostile give-and-takes between shareholders and former chief Richard Jay Kogan. Kogan, who resigned with a $50 million package, was replaced by Hassan just before last year's annual meeting.
On Tuesday, several shareholders thanked Hassan, who came to Schering-Plough after heading Pharmacia Corp.
But others questioned the role of the board of directors, who in the words of Claire Wollock of Wayne, "caused such horror" to the company by not doing enough when Kogan was in charge.
Hassan defended the board, commending its members for remaining loyal to Schering-Plough through its tough times and for making some "tough calls," including changing CEOs.
"It's not easy to make a change at the top," Hassan said.